These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 25556904

  • 1. Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease.
    Roberts DM, Jones RB, Smith RM, Alberici F, Kumaratne DS, Burns S, Jayne DR.
    J Autoimmun; 2015 Feb; 57():60-5. PubMed ID: 25556904
    [Abstract] [Full Text] [Related]

  • 2. Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: a case series.
    Roberts DM, Jones RB, Smith RM, Alberici F, Kumaratne DS, Burns S, Jayne DR.
    J Autoimmun; 2015 Feb; 57():24-9. PubMed ID: 25586449
    [Abstract] [Full Text] [Related]

  • 3. Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease.
    Tieu J, Smith RM, Gopaluni S, Kumararatne DS, McClure M, Manson A, Houghton S, Jayne DRW.
    Front Immunol; 2021 Feb; 12():671503. PubMed ID: 34054846
    [Abstract] [Full Text] [Related]

  • 4. Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases.
    Khojah AM, Miller ML, Klein-Gitelman MS, Curran ML, Hans V, Pachman LM, Fuleihan RL.
    Pediatr Rheumatol Online J; 2019 Aug 28; 17(1):61. PubMed ID: 31462263
    [Abstract] [Full Text] [Related]

  • 5. The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease.
    Marco H, Smith RM, Jones RB, Guerry MJ, Catapano F, Burns S, Chaudhry AN, Smith KG, Jayne DR.
    BMC Musculoskelet Disord; 2014 May 25; 15():178. PubMed ID: 24884562
    [Abstract] [Full Text] [Related]

  • 6. Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients.
    Labrosse R, Barmettler S, Derfalvi B, Blincoe A, Cros G, Lacombe-Barrios J, Barsalou J, Yang N, Alrumayyan N, Sinclair J, Ong MS, Camargo CA, Walter J, Haddad E.
    J Allergy Clin Immunol; 2021 Aug 25; 148(2):523-532.e8. PubMed ID: 33862010
    [Abstract] [Full Text] [Related]

  • 7. Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab.
    Besada E.
    BMC Musculoskelet Disord; 2016 Jan 06; 17():6. PubMed ID: 26738559
    [Abstract] [Full Text] [Related]

  • 8. Post-rituximab immunoglobulin M (IgM) hypogammaglobulinemia.
    Kridin K, Ahmed AR.
    Autoimmun Rev; 2020 Mar 06; 19(3):102466. PubMed ID: 31917267
    [Abstract] [Full Text] [Related]

  • 9. Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study.
    Wade SD, Kyttaris VC.
    Rheumatol Int; 2021 Jun 06; 41(6):1115-1124. PubMed ID: 33811499
    [Abstract] [Full Text] [Related]

  • 10. Incidence of Profound Hypogammaglobulinemia and Infection Rate in Lymphoma Patients Following the Combination of Chemotherapy and Rituximab.
    Filanovsky K, Miller EB, Sigler E, Berrebi A, Shvidel L.
    Recent Pat Anticancer Drug Discov; 2016 Jun 06; 11(2):228-35. PubMed ID: 26825174
    [Abstract] [Full Text] [Related]

  • 11. Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia.
    Spadaro G, Pecoraro A, De Renzo A, Della Pepa R, Genovese A.
    Clin Immunol; 2016 May 06; 166-167():103-4. PubMed ID: 27063866
    [Abstract] [Full Text] [Related]

  • 12. Rituximab in myasthenia gravis: efficacy, associated infections and risk of induced hypogammaglobulinemia.
    Caballero-Ávila M, Álvarez-Velasco R, Moga E, Rojas-Garcia R, Turon-Sans J, Querol L, Olivé M, Reyes-Leiva D, Illa I, Gallardo E, Cortés-Vicente E.
    Neuromuscul Disord; 2022 Aug 06; 32(8):664-671. PubMed ID: 35811274
    [Abstract] [Full Text] [Related]

  • 13. Predictors of hypogammaglobulinemia and serious infections among patients receiving ocrelizumab or rituximab for treatment of MS and NMOSD.
    Mears V, Jakubecz C, Seeco C, Woodson S, Serra A, Abboud H.
    J Neuroimmunol; 2023 Apr 15; 377():578066. PubMed ID: 36917920
    [Abstract] [Full Text] [Related]

  • 14. Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.
    Barmettler S, Ong MS, Farmer JR, Choi H, Walter J.
    JAMA Netw Open; 2018 Nov 02; 1(7):e184169. PubMed ID: 30646343
    [Abstract] [Full Text] [Related]

  • 15. Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults.
    McAtee CL, Lubega J, Underbrink K, Curry K, Msaouel P, Barrow M, Muscal E, Lotze T, Srivaths P, Forbes LR, Allen C, Bernhardt MB.
    JAMA Netw Open; 2021 Feb 01; 4(2):e2036321. PubMed ID: 33533931
    [Abstract] [Full Text] [Related]

  • 16. Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: Systematic literature review.
    Wijetilleka S, Mukhtyar C, Jayne D, Ala A, Bright P, Chinoy H, Harper L, Kazmi M, Kiani-Alikhan S, Li C, Misbah S, Oni L, Price-Kuehne F, Salama A, Workman S, Wrench D, Karim MY.
    Autoimmun Rev; 2019 May 01; 18(5):535-541. PubMed ID: 30844552
    [Abstract] [Full Text] [Related]

  • 17. Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome.
    Inoki Y, Kamei K, Nishi K, Sato M, Ogura M, Ishiguro A.
    Pediatr Nephrol; 2022 May 01; 37(5):1057-1066. PubMed ID: 34606002
    [Abstract] [Full Text] [Related]

  • 18. Hypogammaglobulinemia after rituximab for rheumatoid arthritis is not rare and is related with good response: 13 years real-life experience.
    Evangelatos G, Fragoulis GE, Klavdianou K, Moschopoulou M, Vassilopoulos D, Iliopoulos A.
    Rheumatology (Oxford); 2021 May 14; 60(5):2375-2382. PubMed ID: 33175958
    [Abstract] [Full Text] [Related]

  • 19. Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia.
    Otremba MD, Adam SI, Price CC, Hohuan D, Kveton JF.
    Am J Otolaryngol; 2012 May 14; 33(5):619-22. PubMed ID: 22361345
    [Abstract] [Full Text] [Related]

  • 20. Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases.
    Md Yusof MY, Vital EM, McElvenny DM, Hensor EMA, Das S, Dass S, Rawstron AC, Buch MH, Emery P, Savic S.
    Arthritis Rheumatol; 2019 Nov 14; 71(11):1812-1823. PubMed ID: 31131994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.